SEC

Co-Diagnostics, a company that has provided coronavirus tests to three state governments, has come under intense scrutiny for claims about its tests' accuracy and stock sales by company leaders.

The recent stock sales by the North Carolina Republican were a market-beating anomaly that didn't match his typically middling trading history, according to a new Dartmouth College analysis.